nodes	percent_of_prediction	percent_of_DWPC	metapath
Nalbuphine—Cramp muscle—Spironolactone—dilated cardiomyopathy	0.0273	0.0353	CcSEcCtD
Nalbuphine—Laryngeal oedema—Lisinopril—dilated cardiomyopathy	0.0266	0.0343	CcSEcCtD
Nalbuphine—Swelling—Furosemide—dilated cardiomyopathy	0.0187	0.0242	CcSEcCtD
Nalbuphine—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.0175	0.0227	CcSEcCtD
Nalbuphine—Wheezing—Lisinopril—dilated cardiomyopathy	0.0166	0.0214	CcSEcCtD
Nalbuphine—Pulmonary oedema—Lisinopril—dilated cardiomyopathy	0.0152	0.0196	CcSEcCtD
Nalbuphine—Confusional state—Spironolactone—dilated cardiomyopathy	0.015	0.0194	CcSEcCtD
Nalbuphine—Cramp muscle—Furosemide—dilated cardiomyopathy	0.0148	0.0192	CcSEcCtD
Nalbuphine—Somnolence—Spironolactone—dilated cardiomyopathy	0.0132	0.0171	CcSEcCtD
Nalbuphine—Pollakiuria—Furosemide—dilated cardiomyopathy	0.0132	0.017	CcSEcCtD
Nalbuphine—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.0123	0.0159	CcSEcCtD
Nalbuphine—Urticaria—Spironolactone—dilated cardiomyopathy	0.0118	0.0153	CcSEcCtD
Nalbuphine—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.0118	0.0152	CcSEcCtD
Nalbuphine—Cardiac arrest—Lisinopril—dilated cardiomyopathy	0.0118	0.0152	CcSEcCtD
Nalbuphine—Cramp muscle—Lisinopril—dilated cardiomyopathy	0.0111	0.0144	CcSEcCtD
Nalbuphine—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.011	0.0142	CcSEcCtD
Nalbuphine—Asthma—Lisinopril—dilated cardiomyopathy	0.0107	0.0138	CcSEcCtD
Nalbuphine—Pruritus—Spironolactone—dilated cardiomyopathy	0.0105	0.0136	CcSEcCtD
Nalbuphine—Bronchospasm—Lisinopril—dilated cardiomyopathy	0.0105	0.0136	CcSEcCtD
Nalbuphine—Sweating increased—Lisinopril—dilated cardiomyopathy	0.0104	0.0135	CcSEcCtD
Nalbuphine—Erythema—Furosemide—dilated cardiomyopathy	0.00993	0.0128	CcSEcCtD
Nalbuphine—Dizziness—Spironolactone—dilated cardiomyopathy	0.00985	0.0127	CcSEcCtD
Nalbuphine—Dysgeusia—Furosemide—dilated cardiomyopathy	0.00972	0.0126	CcSEcCtD
Nalbuphine—Muscle spasms—Furosemide—dilated cardiomyopathy	0.00955	0.0123	CcSEcCtD
Nalbuphine—Depression—Lisinopril—dilated cardiomyopathy	0.00951	0.0123	CcSEcCtD
Nalbuphine—Vomiting—Spironolactone—dilated cardiomyopathy	0.00947	0.0122	CcSEcCtD
Nalbuphine—Rash—Spironolactone—dilated cardiomyopathy	0.00939	0.0121	CcSEcCtD
Nalbuphine—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00938	0.0121	CcSEcCtD
Nalbuphine—Vision blurred—Furosemide—dilated cardiomyopathy	0.00936	0.0121	CcSEcCtD
Nalbuphine—Headache—Spironolactone—dilated cardiomyopathy	0.00933	0.0121	CcSEcCtD
Nalbuphine—Agitation—Furosemide—dilated cardiomyopathy	0.00913	0.0118	CcSEcCtD
Nalbuphine—Vertigo—Furosemide—dilated cardiomyopathy	0.00892	0.0115	CcSEcCtD
Nalbuphine—Nausea—Spironolactone—dilated cardiomyopathy	0.00885	0.0114	CcSEcCtD
Nalbuphine—Bradycardia—Lisinopril—dilated cardiomyopathy	0.00871	0.0113	CcSEcCtD
Nalbuphine—Hallucination—Lisinopril—dilated cardiomyopathy	0.00852	0.011	CcSEcCtD
Nalbuphine—Dry mouth—Furosemide—dilated cardiomyopathy	0.00827	0.0107	CcSEcCtD
Nalbuphine—Confusional state—Furosemide—dilated cardiomyopathy	0.00817	0.0106	CcSEcCtD
Nalbuphine—Shock—Furosemide—dilated cardiomyopathy	0.00797	0.0103	CcSEcCtD
Nalbuphine—Flushing—Lisinopril—dilated cardiomyopathy	0.00794	0.0103	CcSEcCtD
Nalbuphine—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.00783	0.0101	CcSEcCtD
Nalbuphine—Hypotension—Furosemide—dilated cardiomyopathy	0.00757	0.00979	CcSEcCtD
Nalbuphine—Erythema—Lisinopril—dilated cardiomyopathy	0.00745	0.00963	CcSEcCtD
Nalbuphine—Tension—Lisinopril—dilated cardiomyopathy	0.00731	0.00945	CcSEcCtD
Nalbuphine—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.0073	0.00943	CcSEcCtD
Nalbuphine—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00728	0.00941	CcSEcCtD
Nalbuphine—Nervousness—Lisinopril—dilated cardiomyopathy	0.00724	0.00936	CcSEcCtD
Nalbuphine—Somnolence—Furosemide—dilated cardiomyopathy	0.0072	0.00932	CcSEcCtD
Nalbuphine—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.00716	0.00926	CcSEcCtD
Nalbuphine—Vision blurred—Lisinopril—dilated cardiomyopathy	0.00702	0.00908	CcSEcCtD
Nalbuphine—Tremor—Lisinopril—dilated cardiomyopathy	0.00698	0.00903	CcSEcCtD
Nalbuphine—Vertigo—Lisinopril—dilated cardiomyopathy	0.00669	0.00866	CcSEcCtD
Nalbuphine—Syncope—Lisinopril—dilated cardiomyopathy	0.00668	0.00864	CcSEcCtD
Nalbuphine—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00668	0.00864	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00663	0.00857	CcSEcCtD
Nalbuphine—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.00655	0.00847	CcSEcCtD
Nalbuphine—Urticaria—Furosemide—dilated cardiomyopathy	0.00644	0.00833	CcSEcCtD
Nalbuphine—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00641	0.00828	CcSEcCtD
Nalbuphine—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00641	0.00828	CcSEcCtD
Nalbuphine—Anxiety—Lisinopril—dilated cardiomyopathy	0.00632	0.00817	CcSEcCtD
Nalbuphine—Dry mouth—Lisinopril—dilated cardiomyopathy	0.0062	0.00802	CcSEcCtD
Nalbuphine—Confusional state—Lisinopril—dilated cardiomyopathy	0.00613	0.00793	CcSEcCtD
Nalbuphine—Oedema—Lisinopril—dilated cardiomyopathy	0.00608	0.00786	CcSEcCtD
Nalbuphine—Shock—Lisinopril—dilated cardiomyopathy	0.00598	0.00774	CcSEcCtD
Nalbuphine—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00597	0.00772	CcSEcCtD
Nalbuphine—Tachycardia—Lisinopril—dilated cardiomyopathy	0.00593	0.00767	CcSEcCtD
Nalbuphine—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.00588	0.0076	CcSEcCtD
Nalbuphine—OPRD1—Peptide GPCRs—AGTR2—dilated cardiomyopathy	0.00584	0.0257	CbGpPWpGaD
Nalbuphine—Asthenia—Furosemide—dilated cardiomyopathy	0.00581	0.00752	CcSEcCtD
Nalbuphine—Pruritus—Furosemide—dilated cardiomyopathy	0.00573	0.00741	CcSEcCtD
Nalbuphine—Hypotension—Lisinopril—dilated cardiomyopathy	0.00568	0.00735	CcSEcCtD
Nalbuphine—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.00546	0.00706	CcSEcCtD
Nalbuphine—OPRD1—Peptide GPCRs—CXCR3—dilated cardiomyopathy	0.00543	0.0239	CbGpPWpGaD
Nalbuphine—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.00542	0.00701	CcSEcCtD
Nalbuphine—Somnolence—Lisinopril—dilated cardiomyopathy	0.00541	0.00699	CcSEcCtD
Nalbuphine—Dizziness—Furosemide—dilated cardiomyopathy	0.00536	0.00693	CcSEcCtD
Nalbuphine—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.00535	0.00692	CcSEcCtD
Nalbuphine—Vomiting—Furosemide—dilated cardiomyopathy	0.00515	0.00666	CcSEcCtD
Nalbuphine—OPRK1—Peptide GPCRs—AGTR2—dilated cardiomyopathy	0.00512	0.0226	CbGpPWpGaD
Nalbuphine—OPRD1—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.00512	0.0226	CbGpPWpGaD
Nalbuphine—Rash—Furosemide—dilated cardiomyopathy	0.00511	0.00661	CcSEcCtD
Nalbuphine—Dermatitis—Furosemide—dilated cardiomyopathy	0.00511	0.0066	CcSEcCtD
Nalbuphine—Headache—Furosemide—dilated cardiomyopathy	0.00508	0.00656	CcSEcCtD
Nalbuphine—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.00501	0.00648	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.00497	0.00643	CcSEcCtD
Nalbuphine—Urticaria—Lisinopril—dilated cardiomyopathy	0.00483	0.00625	CcSEcCtD
Nalbuphine—Nausea—Furosemide—dilated cardiomyopathy	0.00481	0.00622	CcSEcCtD
Nalbuphine—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.00481	0.00622	CcSEcCtD
Nalbuphine—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.00481	0.00622	CcSEcCtD
Nalbuphine—OPRK1—Peptide GPCRs—CXCR3—dilated cardiomyopathy	0.00476	0.021	CbGpPWpGaD
Nalbuphine—OPRD1—Peptide GPCRs—AGTR1—dilated cardiomyopathy	0.00449	0.0198	CbGpPWpGaD
Nalbuphine—OPRK1—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.00449	0.0198	CbGpPWpGaD
Nalbuphine—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00448	0.00579	CcSEcCtD
Nalbuphine—Asthenia—Lisinopril—dilated cardiomyopathy	0.00436	0.00564	CcSEcCtD
Nalbuphine—OPRM1—Peptide GPCRs—AGTR2—dilated cardiomyopathy	0.00432	0.0191	CbGpPWpGaD
Nalbuphine—Pruritus—Lisinopril—dilated cardiomyopathy	0.0043	0.00556	CcSEcCtD
Nalbuphine—Dizziness—Lisinopril—dilated cardiomyopathy	0.00402	0.0052	CcSEcCtD
Nalbuphine—OPRM1—Peptide GPCRs—CXCR3—dilated cardiomyopathy	0.00402	0.0177	CbGpPWpGaD
Nalbuphine—OPRK1—Peptide GPCRs—AGTR1—dilated cardiomyopathy	0.00393	0.0174	CbGpPWpGaD
Nalbuphine—Vomiting—Lisinopril—dilated cardiomyopathy	0.00387	0.005	CcSEcCtD
Nalbuphine—Rash—Lisinopril—dilated cardiomyopathy	0.00383	0.00496	CcSEcCtD
Nalbuphine—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00383	0.00495	CcSEcCtD
Nalbuphine—Headache—Lisinopril—dilated cardiomyopathy	0.00381	0.00493	CcSEcCtD
Nalbuphine—OPRM1—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.00379	0.0167	CbGpPWpGaD
Nalbuphine—Nausea—Lisinopril—dilated cardiomyopathy	0.00361	0.00467	CcSEcCtD
Nalbuphine—OPRM1—Peptide GPCRs—AGTR1—dilated cardiomyopathy	0.00333	0.0147	CbGpPWpGaD
Nalbuphine—OPRM1—IL4-mediated signaling events—IL10—dilated cardiomyopathy	0.00321	0.0142	CbGpPWpGaD
Nalbuphine—OPRM1—IL4-mediated signaling events—RPS6KB1—dilated cardiomyopathy	0.00312	0.0138	CbGpPWpGaD
Nalbuphine—OPRD1—Peptide ligand-binding receptors—CXCL2—dilated cardiomyopathy	0.00274	0.0121	CbGpPWpGaD
Nalbuphine—OPRD1—Peptide ligand-binding receptors—AGTR2—dilated cardiomyopathy	0.00274	0.0121	CbGpPWpGaD
Nalbuphine—OPRD1—Peptide ligand-binding receptors—CXCR3—dilated cardiomyopathy	0.00255	0.0113	CbGpPWpGaD
Nalbuphine—OPRK1—Peptide ligand-binding receptors—AGTR2—dilated cardiomyopathy	0.00241	0.0106	CbGpPWpGaD
Nalbuphine—OPRK1—Peptide ligand-binding receptors—CXCL2—dilated cardiomyopathy	0.00241	0.0106	CbGpPWpGaD
Nalbuphine—OPRD1—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.00232	0.0102	CbGpPWpGaD
Nalbuphine—OPRD1—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.00232	0.0102	CbGpPWpGaD
Nalbuphine—OPRK1—Peptide ligand-binding receptors—CXCR3—dilated cardiomyopathy	0.00224	0.00987	CbGpPWpGaD
Nalbuphine—OPRD1—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.00215	0.0095	CbGpPWpGaD
Nalbuphine—OPRD1—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.00215	0.00948	CbGpPWpGaD
Nalbuphine—OPRM1—TCR Signaling Pathway—FAS—dilated cardiomyopathy	0.00214	0.00942	CbGpPWpGaD
Nalbuphine—OPRD1—Peptide ligand-binding receptors—AGTR1—dilated cardiomyopathy	0.00211	0.00931	CbGpPWpGaD
Nalbuphine—OPRM1—Peptide ligand-binding receptors—CXCL2—dilated cardiomyopathy	0.00203	0.00897	CbGpPWpGaD
Nalbuphine—OPRM1—Peptide ligand-binding receptors—AGTR2—dilated cardiomyopathy	0.00203	0.00897	CbGpPWpGaD
Nalbuphine—OPRK1—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.00203	0.00896	CbGpPWpGaD
Nalbuphine—OPRK1—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.00203	0.00896	CbGpPWpGaD
Nalbuphine—OPRD1—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.002	0.00881	CbGpPWpGaD
Nalbuphine—OPRD1—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.00193	0.00854	CbGpPWpGaD
Nalbuphine—OPRM1—Peptide ligand-binding receptors—CXCR3—dilated cardiomyopathy	0.00189	0.00834	CbGpPWpGaD
Nalbuphine—OPRK1—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.00189	0.00833	CbGpPWpGaD
Nalbuphine—OPRK1—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.00188	0.00831	CbGpPWpGaD
Nalbuphine—OPRK1—Peptide ligand-binding receptors—AGTR1—dilated cardiomyopathy	0.00185	0.00817	CbGpPWpGaD
Nalbuphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00184	0.00812	CbGpPWpGaD
Nalbuphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00184	0.00812	CbGpPWpGaD
Nalbuphine—OPRK1—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00175	0.00773	CbGpPWpGaD
Nalbuphine—OPRM1—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.00172	0.00757	CbGpPWpGaD
Nalbuphine—OPRM1—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.00172	0.00757	CbGpPWpGaD
Nalbuphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00171	0.00755	CbGpPWpGaD
Nalbuphine—OPRK1—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.0017	0.00748	CbGpPWpGaD
Nalbuphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00166	0.00731	CbGpPWpGaD
Nalbuphine—OPRD1—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00165	0.00729	CbGpPWpGaD
Nalbuphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00161	0.00712	CbGpPWpGaD
Nalbuphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00161	0.00712	CbGpPWpGaD
Nalbuphine—OPRM1—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.0016	0.00704	CbGpPWpGaD
Nalbuphine—OPRM1—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.00159	0.00703	CbGpPWpGaD
Nalbuphine—OPRD1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00157	0.00692	CbGpPWpGaD
Nalbuphine—OPRM1—Peptide ligand-binding receptors—AGTR1—dilated cardiomyopathy	0.00156	0.0069	CbGpPWpGaD
Nalbuphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.0015	0.00662	CbGpPWpGaD
Nalbuphine—OPRD1—Peptide ligand-binding receptors—AGT—dilated cardiomyopathy	0.00149	0.00655	CbGpPWpGaD
Nalbuphine—OPRM1—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00148	0.00653	CbGpPWpGaD
Nalbuphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00145	0.00641	CbGpPWpGaD
Nalbuphine—OPRK1—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00145	0.00639	CbGpPWpGaD
Nalbuphine—OPRM1—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.00143	0.00633	CbGpPWpGaD
Nalbuphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00142	0.00625	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.0014	0.00619	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.0014	0.00619	CbGpPWpGaD
Nalbuphine—OPRM1—TCR Signaling Pathway—RAF1—dilated cardiomyopathy	0.00139	0.00613	CbGpPWpGaD
Nalbuphine—OPRK1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00137	0.00606	CbGpPWpGaD
Nalbuphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00136	0.00602	CbGpPWpGaD
Nalbuphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00136	0.00602	CbGpPWpGaD
Nalbuphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00134	0.00593	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.0013	0.00575	CbGpPWpGaD
Nalbuphine—OPRK1—Peptide ligand-binding receptors—AGT—dilated cardiomyopathy	0.0013	0.00575	CbGpPWpGaD
Nalbuphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00127	0.0056	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00126	0.00557	CbGpPWpGaD
Nalbuphine—OPRD1—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.00125	0.00553	CbGpPWpGaD
Nalbuphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00124	0.00548	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00123	0.00542	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00123	0.00542	CbGpPWpGaD
Nalbuphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00123	0.00542	CbGpPWpGaD
Nalbuphine—OPRM1—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00122	0.0054	CbGpPWpGaD
Nalbuphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00118	0.0052	CbGpPWpGaD
Nalbuphine—OPRM1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00116	0.00513	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00114	0.00504	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00111	0.00488	CbGpPWpGaD
Nalbuphine—OPRM1—Peptide ligand-binding receptors—AGT—dilated cardiomyopathy	0.0011	0.00486	CbGpPWpGaD
Nalbuphine—OPRK1—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.0011	0.00485	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00108	0.00476	CbGpPWpGaD
Nalbuphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00105	0.00463	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00104	0.00458	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00104	0.00458	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.00102	0.00451	CbGpPWpGaD
Nalbuphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000996	0.0044	CbGpPWpGaD
Nalbuphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000995	0.00439	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000966	0.00426	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000945	0.00417	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000935	0.00413	CbGpPWpGaD
Nalbuphine—OPRM1—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.000929	0.0041	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000897	0.00396	CbGpPWpGaD
Nalbuphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000874	0.00385	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000799	0.00352	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000792	0.0035	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000792	0.0035	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000759	0.00335	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000758	0.00334	CbGpPWpGaD
Nalbuphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000738	0.00326	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000737	0.00325	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000719	0.00317	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000719	0.00317	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000713	0.00315	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000695	0.00307	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000695	0.00307	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000669	0.00295	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000665	0.00293	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000648	0.00286	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000646	0.00285	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000631	0.00278	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000631	0.00278	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000625	0.00276	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000609	0.00269	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000587	0.00259	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000587	0.00259	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000586	0.00259	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000578	0.00255	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000568	0.00251	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000562	0.00248	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000553	0.00244	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000546	0.00241	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000534	0.00236	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000533	0.00235	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000533	0.00235	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000529	0.00233	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000525	0.00232	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000507	0.00224	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000496	0.00219	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000485	0.00214	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.00048	0.00212	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000479	0.00211	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.00046	0.00203	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000451	0.00199	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000449	0.00198	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000429	0.00189	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000428	0.00189	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000425	0.00188	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000425	0.00188	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.00042	0.00185	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.00041	0.00181	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000407	0.0018	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000395	0.00174	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000393	0.00174	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000389	0.00172	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000389	0.00172	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000383	0.00169	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000376	0.00166	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000373	0.00164	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000373	0.00164	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000357	0.00158	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000355	0.00157	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000346	0.00153	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000341	0.00151	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000336	0.00148	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000333	0.00147	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000327	0.00144	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000318	0.0014	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000315	0.00139	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000315	0.00139	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.00031	0.00137	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000302	0.00133	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000293	0.00129	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000289	0.00127	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000287	0.00126	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000284	0.00125	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000272	0.0012	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.00027	0.00119	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000266	0.00118	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000242	0.00107	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000241	0.00106	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000237	0.00105	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000234	0.00103	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—AGT—dilated cardiomyopathy	0.00023	0.00101	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.00023	0.00101	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000211	0.000931	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—AGT—dilated cardiomyopathy	0.000202	0.00089	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.0002	0.000883	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000197	0.000871	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000185	0.000817	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000178	0.000787	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—AGT—dilated cardiomyopathy	0.00017	0.000752	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000162	0.000717	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—RAF1—dilated cardiomyopathy	0.00016	0.000704	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—RAF1—dilated cardiomyopathy	0.00014	0.000617	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000137	0.000606	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000118	0.000522	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000109	0.000483	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—EGFR—dilated cardiomyopathy	9.6e-05	0.000423	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—EGFR—dilated cardiomyopathy	8.11e-05	0.000358	CbGpPWpGaD
